Medical Devices


  • A photo of Monogram Orthopedics' surgical robot.
    Image attribution tooltip
    Permission granted by Monogram Orthopedics
    Image attribution tooltip

    Zimmer submits Monogram robot to FDA

    The company is targeting Food and Drug Administration clearance next year for an autonomous orthopedic robot.

    By • Nov. 20, 2026
  • Three components of Johnson & Johnson's Ottava robotic surgery system are displayed.
    Image attribution tooltip
    Courtesy of Johnson & Johnson
    Image attribution tooltip

    J&J to install first Ottava robot in US hospital

    The commercial agreement with Memorial Hermann-Texas Medical Center comes in the same week that rival Medtronic revealed expanded FDA clearance for its Hugo robot in general surgical procedures.

    By • Nov. 20, 2026
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland. Explore the Trendline➔
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip
    Trendline

    Top 5 stories from MedTech Dive

    From the effects of layoffs at the Food and Drug Administration and President Donald Trump’s tariff policies to the top medtech trends of 2026, here is a collection of top stories from MedTech Dive.

    By MedTech Dive staff
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott starts trial of Encantor transcatheter aortic valve

    The balloon-expandable system could complement Abbott’s existing self-expanding Navitor device.

    By • Nov. 20, 2026
  • Four clinicians with a robotic surgery system in an operating room.
    Image attribution tooltip
    Permission granted by Remedy Robotics
    Image attribution tooltip

    Remedy Robotics raises $62M; Capstan’s mitral replacement robot progresses

    Remedy plans a pivotal trial and has its sights on bringing to market a system for neurovascular intervention, while Capstan Medical performed the first U.S. transcatheter mitral valve replacement with its investigational robot.

    By • Nov. 18, 2026
  • eye
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Science Corporation raises $400M to commercialize BCI device

    The device, which Science has launched in Europe, is designed to restore the sight of people with some forms of vision loss.

    By • Nov. 18, 2026
  • Four components of Medtronic's Hugo robotic surgery system are shown.
    Image attribution tooltip
    Permission granted by Medtronic
    Image attribution tooltip

    Medtronic’s Hugo robot gets expanded FDA clearance in general surgery

    The specialties gaining authorization account for more than half of the soft tissue procedures performed annually in the U.S.

    By • Nov. 17, 2026
  • Businessman and woman connect lightbulb with money dollar sign
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Galvanize raises $130M to advance pulsed electric field ablation

    The Series D round will support commercialization of Galvanize’s soft-tissue ablation platform and development of a chronic bronchitis device.

    By • Nov. 17, 2026
  • The exterior of Medtronic's Minnesota operational headquarters is shown along with its reflection in a pool of water.
    Image attribution tooltip
    Courtesy of Medtronic
    Image attribution tooltip

    Medtronic to buy Contego Medical for $380M

    The deal is intended to expand Medtronic’s portfolio of carotid artery and peripheral vascular disease treatments.

    By • Nov. 16, 2026
  • A person wearing a bikini sits on a chair, with a rectangular device stuck to their abdomen.
    Image attribution tooltip
    Courtesy of Tandem Diabetes Care
    Image attribution tooltip

    Tandem wins FDA clearance for tubeless automated insulin delivery system

    The clearance tees up a 2027 launch of a product that analysts called Tandem’s “single most important commercial catalyst and growth driver.”

    By • Nov. 16, 2026
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA posts early alerts for 2 product removals

    Intersurgical told customers to immediately stop using affected devices, while Arrow International instructed users to quarantine and return certain products.

    By • Nov. 13, 2026
  • A headshot of new Olympus CEO Bob White.
    Image attribution tooltip
    Courtesy of Olympus
    Image attribution tooltip

    Olympus making strides on FDA quality concerns, CEO says

    CEO Bob White said the endoscope manufacturer accelerated its remediation and quality improvement efforts to “provide the sustained evidence that the agency is expecting.”

    By • Nov. 13, 2026
  • A close-up picture of a one hundred dollar bill
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    J&J leads Francis Medical investment to fund prostate cancer device

    With Johnson & Johnson’s support, Francis plans to take its water-vapor therapy device through the premarket approval process.

    By • Nov. 12, 2026
  • A robotic surgery system is displayed.
    Image attribution tooltip
    Courtesy of Virtuoso Surgical
    Image attribution tooltip

    Virtuoso robot wins FDA nod for bladder tumor removal

    Virtuoso Surgical’s robotic system can remove lesions in one piece in a minimally invasive procedure designed to improve cancer diagnosis and staging.

    By • Nov. 10, 2026
  • A picture of Getinge's headquarters building in Gothenburg, Sweden.
    Image attribution tooltip
    Courtesy of Getinge
    Image attribution tooltip

    Getinge hires president of acute care therapies

    Stacy Beske joins Getinge from Philips and will take over the role on Dec. 1.

    By • Nov. 10, 2026
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    Novocure denied FDA approval for metastatic cancer treatment

    The FDA had uncertainty about the degree of clinical benefit for Novocure’s treatment of brain metastases, the company said.

    By • Nov. 9, 2026
  • A patient on a stretcher in a hospital corridor interacts with a doctor.
    Image attribution tooltip
    Courtesy of AdventHealth
    Image attribution tooltip

    FDA seeks input on telesurgery, autonomous robotics

    The agency is inviting public comment on a new discussion paper as it prepares to shape policy covering robotic medical devices with autonomous or remote teleoperation functions.

    By • Nov. 9, 2026
  • An image of Edwards Lifesciences' Irvine, California, campus at dusk.
    Image attribution tooltip
    Courtesy of Edwards Lifesciences
    Image attribution tooltip

    Edwards bumps up sales forecast on TAVR strength in Q3

    Going forward, the heart valve maker expects procedure volumes to rise following positive study data and expanded Medicare reimbursement.

    By • Nov. 5, 2026
  • Boston Scientific's headquarters building is shown.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific, Blackstone agree to $455M deal to co-fund heart pump development

    As part of the agreement, Blackstone may receive regulatory and commercial milestone payments, plus royalties on net sales. 

    By • Nov. 5, 2026
  • A person sits at a table with food, wearing a pink, rectangular device attached to a striped dress.
    Image attribution tooltip
    Courtesy of MiniMed
    Image attribution tooltip

    MiniMed names David Segal chief medical officer

    Segal is succeeding Robert Vigersky, who is transitioning to a chief medical officer emeritus role ahead of his planned retirement at the end of next year.

    By • Nov. 5, 2026
  • A sign for Zimmer Biomet is shown outside of the company's headquarters building.
    Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Zimmer raises sales forecast despite slower knee business

    CEO Ivan Tornos did not attribute the company’s performance in knees to a broader market slowdown, as competitor Stryker did last week.

    By • Nov. 4, 2026
  • Image attribution tooltip
    Patrik Stollarz / Staff via Getty Images
    Image attribution tooltip

    Philips settles with DOJ over recalled CPAP machines

    Philips will pay 288 million euros to settle an investigation related to its recall of millions of sleep and respiratory devices.

    By • Nov. 4, 2026
  • A doctor and patient in the cath lab.
    Image attribution tooltip
    Image Supply via Getty Images
    Image attribution tooltip

    3 takeaways from TCT 2026

    Edwards’ TAVR results in moderate aortic stenosis drew applause from meeting attendees, while Medtronic’s renal denervation and Abbott’s left atrial appendage closure devices also produced positive study findings.

    By • Nov. 4, 2026
  • A person stands at a podium and speaks.
    Image attribution tooltip
    Permission granted by Resmed
    Image attribution tooltip
    Q&A

    AdvaMed Chair Mick Farrell shares his top priorities, challenges for the medtech industry

    In a year where companies are grappling with cyberattacks, inflation and potential tariffs, Farrell, who is also CEO of Resmed, shared a bird’s eye view of the issues.

    By • Nov. 2, 2026
  • Modern glass and metal office building with a reflective blue-tinted facade, set against a clear blue sky. In the foreground, a large black and white sign reads “Abbott” with the company’s stylized logo and the number “645.” The area has neatly cut grass and a few small trees.
    Image attribution tooltip
    Alamy
    Image attribution tooltip

    Abbott starts pivotal trial for mitral valve replacement device

    The study is testing a device that Abbott executives believe can expand the mitral valve market.

    By • Nov. 2, 2026
  • A sign for the Food And Drug Administration is seen outside of the headquarters on July 20, 2020 in White Oak, Maryland.
    Image attribution tooltip
    Sarah Silbiger via Getty Images
    Image attribution tooltip

    FDA posts alert about Medline beds linked to 2 deaths

    The company notified customers this month that it will discontinue Medline brand beds and associated products and exit the market.

    By • Oct. 30, 2026